Enhanced surveillance for congenital rubella syndrome following mass rubella vaccination of girls and reproductive-aged women.
Where this comes from
- Record sourced from PubMed, PMID 21954260.
- Also identified by DOI 10.1093/infdis/jir481.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Chile was the first country in the Americas to conduct surveillance for congenital rubella syndrome (CRS) as part of screening for common causes of congenital birth defects (referred to as TORCH pathogens). The surveillance system identified 15 CRS cases in 1999 and 2 cases in 2000, and it has identified no CRS cases since 2000. CRS surveillance in Chile meets recommended surveillance standards and may serve as a model for CRS surveillance in other countries.
Medical subject headings
- Mass Vaccination
- Population Surveillance
- Rubella Syndrome, Congenital
- Rubella Vaccine